Tissue oxygen saturation (StO 2 ) is a valuable clinical parameter e.g. for intensive care applications or monitoring during surgery. Studies showed that near-infrared spectroscopy (NIRS) based tissue oximeters of different brands give systematically different readings of StO 2 . Usually these readings are linearly correlated and therefore StO 2 readings from one instrument can easily be converted to those of another instrument. However, it is interesting to understand why there is this difference. One reason may be that different brands employ different spectra of hemoglobin. The aim here was to investigate how these different absorption spectra of hemoglobin affect the StO 2 readings. Therefore, we performed changes in StO 2 in a phantom experiment with real human hemoglobin at three different concentrations (26.5, 45 and 70 µM): desaturation by yeast consuming the oxygen and re-saturation by bubbling oxygen gas. The partial pressure of O 2 in the liquid changed from at least 10 kPa to ~0 kPa and ISS OxiplexTS, a frequency-domain NIRS instrument, was used to monitor changes of StO 2 . When we employed two different absorption spectra for hemoglobin, StO 2 values were comparable in the normal physiological range. However, particularly at high and low StO 2 values, a difference of >6 % between these two spectra were noticed. Such a difference of >6 % is substantial and relevant for medical applications. This may partly explain why different brands of NIRS instruments provide different StO 2 readings. The hemoglobin spectra are therefore a factor to be considered for future developments and applications of NIRS oximeters.
INTRODUCTION
Non-invasive and continuous bedside measurement of tissue oxygen saturation (StO 2 ) by near-infrared spectroscopy (NIRS) is relevant for many clinical applications like (neonatal) intensive care or monitoring during surgery. One difference compared to other parameters is that the StO 2 cannot be measured by any other method except NIRS and there is no gold standard available to compare to. Currently, work is under way to define an ISO norm, but it seems that it will be difficult to define a procedure how to determine a gold standard StO 2 . In addition, most manufacturers did not publish their algorithms how to calculate StO 2 from raw optical data. Although this impedes a factual understanding of the origin of these different StO 2 readings it is possible to take some reasonable guesses about the signal processing steps of these algorithms. One fundamental part of such an algorithm must be the absorption spectra of chromophores of interest, i.e. oxyhemoglobin (O 2 Hb) and deoxyhemoglobin (HHb). These spectra are needed to transform the measured light intensities to StO 2 values. Several such spectra have been measured and published, but are not completely congruent even though they are similar.
The aim of this paper was to determine whether such slight deviations would lead to significant differences in StO 2 readings for an instrument with a published algorithm.
METHODS

Instrument
In this study, we employed the commercially available OxiplexTS (ISS, Champaign, Illinois, USA) frequency-domain NIRS device. This device was chosen because all raw data is completely accessible and the algorithm to calculate the StO 2 has been published [3] [4] [5] . The OxiplexTS has two light sources (692 nm and 834 nm) whose intensities are modulated with 110 MHz. The light is transmitted to the tissue and the back reflected light is collected by optical fibers. At the detector, the radiofrequency is heterodynely demodulated by modulating the high voltage of the photomultiplier tube at 110.005 MHz. The rigid sensor of the OxiplexTS implements a multi-distance geometry with four source-detector separations of 2.5, 3.0, 3.5 and 4.0 cm. For each distance, the mean intensity, amplitude and phase is measured. From the change in the phase and amplitude with distance, the absolute values for the tissue absorption (µ a ) and reduced scattering coefficients are calculated 3 .
Algorithm to calculate StO 2
From the measured µ a values at the two wavelengths, the absolute O 2 Hb and HHb concentration values were calculated according to.
with α the molecular absorption coefficient and c the concentration of the chromophore. In our case, we have a 2 x 2 system of equations for two wavelengths and two chromophores (O 2 Hb and HHb) (equation 2). In addition, since the tissue generally contains a lot of water, this is taken into account by estimating the water concentration (in %) of the medium under investigation and calculating the contribution of the water to µ a (µ a,water ) 5 .
, . ,
Equation 2 can be solved for the concentrations by
For this study we used the standard absorption coefficients of water for the ISS instrument 6 . For the hemoglobin spectra, we used the ones by Wray 7 and Prahl 
Phantom setup
The phantom setup is described in detail by Kleiser et al. 1 and was intended to simulate the head of a preterm infant, a prime application for NIRS. It consisted of a container with a window made of a layer of silicone with optical properties and thickness (2.5 mm) similar to the scalp and skull of a typical neonate. The container was constantly stirred by a magnetic stirrer and heated to keep a temperature of approximately 37°.
The rigid sensor of the OxiplexTS was placed on the window and fixed with a clamp specifically constructed for this purpose. In addition, a partial pressure of oxygen (pO 2 ) sensor (Microx TX trace3, NTH-PSt1, PreSens -Precision Sensing GmbH, Regensburg, Germany) was immersed in the phantom.
The container was first filled with a liquid mainly containing human hemoglobin and Intralipid®, which was added to obtain the desired scattering coefficient of 5.5 cm -1 . In addition, we added buffer to keep the pH at physiological levels. The measurement with the OxiplexTS was started and detector voltage was automatically adjusted. After a few minutes. yeast was added to deoxygenate the hemoglobin. To increase the speed of deoxygenation glucose was added to feed the yeast. Once the pO 2 stabilized at 0 kPa, we started bubbling O 2 gas until the pO 2 was >10 kPa.
The total hemoglobin concentration [tHb] was initially set to 26.5 µM and after two desaturations it was raised in to 45 µM. After a further desaturation, it was increased to 70 µM. This is a range that is typical for neonatal brain.
Data processing
Raw mean values for intensity, amplitude and phase were stored in a computer and absorption and scattering coefficients were calculated according to the ISS algorithm. StO 2 was calculated for the Wray and Prahl spectra separately in a special script of Matlab R2014a (Mathworks, Inc, Mass., USA) according to the equations above.
RESULTS
In Fig. 1 the whole time trace of the experiment is depicted. The StO 2 is displayed for both Wray (in black) and Prahl (in grey) spectra in the top graph. The tHb concentration is indicated in the upper part of the figure. The middle graph displays the pO 2 values and the bottom graph the difference between the StO 2 calculated using Wray spectra and the one for Prahl spectra.
It is visible that the pO 2 linearly decreased initially and once the StO 2 started to decrease, the slope of the pO 2 decrease flattened. The relation between the StO 2 and pO 2 corresponds to the well-known sigmoidal-shaped dissociation curve which is strongly non-linear. The precise shape depends on several factors such as temperature, pH, and pCO 2 . Therefore, it is not straightforward to predict StO 2 from pO 2 . It can however be assumed that at 0 kPa the StO 2 is 0% and at pO 2 > 10 kPa the StO 2 is close to 100%.
At ~90min and ~170 min additional hemoglobin was added. Since this additional hemoglobin contains oxygen, its injection leads to a small increase in pO 2 and StO 2 . It is visible that the noise level increased when the tHb concentration increased. This is due to the lower number of photons that reach the detector and hence an increased contribution of shot noise. During the last desaturation, there are some outliers visible. These occur when the detector voltage is adjusted to reach a higher dynamic range of the instrument. This is needed to cope with the large changes in absorption that are much higher than usual physiological changes. The difference in StO 2 between Wray and Prahl spectra (Fig. 1 bottom) changes with the oxygenation of the hemoglobin. At high StO 2 it reaches 6.5 % and at low StO 2 it corresponds to - It is well-kno that these sm demonstrates differences in
We would li wavelengths For other inst nt to be aware (Fig. 1) . This the systematic depend on the TS instrument e as well. It would be interesting to investigate this effect further. Why are the molecular absorption spectra different between publications? Which of the spectra is more reliable? Maybe further measurements of hemoglobin spectra with a higher accuracy are necessary?
While the Wray spectra were recorded with human blood samples, the Prahl spectra are a mixture of data from two sources and no information is provided how the data was obtained exactly. There are other spectra available 9 .
In our case, we would like to suggest that the Wray 7 spectra, that are employed for the OxiplexTS instrument are more accurate than the Prahl 8 spectra, because the StO 2 (Wray) reaches 100 % StO 2 at pO 2 > 10 kPa and is closer to 0 % StO 2 at pO 2 = 0 kPa which correspond to the expected values, while the StO 2 (Prahl) only reaches 93.5 % StO 2 at pO 2 > 10 kPa and 6.8 % StO 2 at pO 2 = 0 kPa. Also in a recent study 9 to determine the accuracy of the measurement of [HbO 2 ], [Hb] and [tHb] , the spectra of Wray resulted in more accurate values compared to the spectra of Prahl.
CONCLUSION
When we employ two different absorption spectra for hemoglobin, in the normal physiological range StO 2 values were comparable. However, in particular at high and low pO 2 , there is a substantial and relevant difference in StO 2 of >6% between these two spectra. Such a difference >6% is substantial and relevant and may partly explain, why different brands of NIRS instruments provide different StO 2 readings. Thus, the hemoglobin spectra are a factor that needs to be considered for future developments and applications of NIRS oximetry.
